BCYC - Bicycle Therapeutics GAAP EPS of -$0.63 beats by $0.01 revenue of $3.77M misses by $1.11M
Bicycle Therapeutics press release (NASDAQ:BCYC): Q4 GAAP EPS of -$0.63 beats by $0.01. Revenue of $3.77M (-2.1% Y/Y) misses by $1.11M.
For further details see:
Bicycle Therapeutics GAAP EPS of -$0.63 beats by $0.01, revenue of $3.77M misses by $1.11M